2018-2023 Global Narcolepsy Drug Consumption Market Report
- LP 2651028
- 134 Pages
- July 2018
- Healthcare
Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.
The global average price of narcolepsy drug is in the decreasing trend, from 43.3 K USD/Kg in 2012 to 35.7 K USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of narcolepsy drug includes antioxidants type, stimulants type and other types, and the proportion of antioxidants type in 2016 is about 78% in the world.
Narcolepsy drug is widely used for daytime extreme sleepiness, cataplexia and other field. The most proportion of narcolepsy drug is used for cataplexia, and the consumption proportion in 2016 is about 57%.
Over the next five years, LPI(LP Information) projects that Narcolepsy Drug will register a 10.4% CAGR in terms of revenue, reach US$ 3310 million by 2023, from US$ 1830 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Narcolepsy Drug market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Antioxidants Type
Stimulants Type
Other
Segmentation by application:
Daytime Extreme Sleepiness
Cataplexia
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Jazz Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Narcolepsy Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Narcolepsy Drug market by identifying its various subsegments.
Focuses on the key global Narcolepsy Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Narcolepsy Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Narcolepsy Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 Global Narcolepsy Drug Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Narcolepsy Drug Consumption 2013-2023
2.1.2 Narcolepsy Drug Consumption CAGR by Region
2.2 Narcolepsy Drug Segment by Type
2.2.1 Antioxidants Type
2.2.2 Stimulants Type
2.2.3 Other
2.3 Narcolepsy Drug Consumption by Type
2.3.1 Global Narcolepsy Drug Consumption Market Share by Type (2013-2018)
2.3.2 Global Narcolepsy Drug Revenue and Market Share by Type (2013-2018)
2.3.3 Global Narcolepsy Drug Sale Price by Type (2013-2018)
2.4 Narcolepsy Drug Segment by Application
2.4.1 Daytime Extreme Sleepiness
2.4.2 Cataplexia
2.4.3 Others
2.5 Narcolepsy Drug Consumption by Application
2.5.1 Global Narcolepsy Drug Consumption Market Share by Application (2013-2018)
2.5.2 Global Narcolepsy Drug Value and Market Share by Application (2013-2018)
2.5.3 Global Narcolepsy Drug Sale Price by Application (2013-2018)
3 Global Narcolepsy Drug by Players
3.1 Global Narcolepsy Drug Sales Market Share by Players
3.1.1 Global Narcolepsy Drug Sales by Players (2016-2018)
3.1.2 Global Narcolepsy Drug Sales Market Share by Players (2016-2018)
3.2 Global Narcolepsy Drug Revenue Market Share by Players
3.2.1 Global Narcolepsy Drug Revenue by Players (2016-2018)
3.2.2 Global Narcolepsy Drug Revenue Market Share by Players (2016-2018)
3.3 Global Narcolepsy Drug Sale Price by Players
3.4 Global Narcolepsy Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Narcolepsy Drug Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Narcolepsy Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Narcolepsy Drug by Regions
4.1 Narcolepsy Drug by Regions
4.1.1 Global Narcolepsy Drug Consumption by Regions
4.1.2 Global Narcolepsy Drug Value by Regions
4.2 Americas Narcolepsy Drug Consumption Growth
4.3 APAC Narcolepsy Drug Consumption Growth
4.4 Europe Narcolepsy Drug Consumption Growth
4.5 Middle East & Africa Narcolepsy Drug Consumption Growth
5 Americas
5.1 Americas Narcolepsy Drug Consumption by Countries
5.1.1 Americas Narcolepsy Drug Consumption by Countries (2013-2018)
5.1.2 Americas Narcolepsy Drug Value by Countries (2013-2018)
5.2 Americas Narcolepsy Drug Consumption by Type
5.3 Americas Narcolepsy Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Narcolepsy Drug Consumption by Countries
6.1.1 APAC Narcolepsy Drug Consumption by Countries (2013-2018)
6.1.2 APAC Narcolepsy Drug Value by Countries (2013-2018)
6.2 APAC Narcolepsy Drug Consumption by Type
6.3 APAC Narcolepsy Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Narcolepsy Drug by Countries
7.1.1 Europe Narcolepsy Drug Consumption by Countries (2013-2018)
7.1.2 Europe Narcolepsy Drug Value by Countries (2013-2018)
7.2 Europe Narcolepsy Drug Consumption by Type
7.3 Europe Narcolepsy Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Narcolepsy Drug by Countries
8.1.1 Middle East & Africa Narcolepsy Drug Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Narcolepsy Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Narcolepsy Drug Consumption by Type
8.3 Middle East & Africa Narcolepsy Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Narcolepsy Drug Distributors
10.3 Narcolepsy Drug Customer
11 Global Narcolepsy Drug Market Forecast
11.1 Global Narcolepsy Drug Consumption Forecast (2018-2023)
11.2 Global Narcolepsy Drug Forecast by Regions
11.2.1 Global Narcolepsy Drug Forecast by Regions (2018-2023)
11.2.2 Global Narcolepsy Drug Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Narcolepsy Drug Forecast by Type
11.8 Global Narcolepsy Drug Forecast by Application
12 Key Players Analysis
12.1 Jazz Pharmaceuticals
12.1.1 Company Details
12.1.2 Narcolepsy Drug Product Offered
12.1.3 Jazz Pharmaceuticals Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Jazz Pharmaceuticals News
12.2 Teva Pharmaceutical
12.2.1 Company Details
12.2.2 Narcolepsy Drug Product Offered
12.2.3 Teva Pharmaceutical Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Teva Pharmaceutical News
12.3 Novartis
12.3.1 Company Details
12.3.2 Narcolepsy Drug Product Offered
12.3.3 Novartis Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Novartis News
12.4 Mylan
12.4.1 Company Details
12.4.2 Narcolepsy Drug Product Offered
12.4.3 Mylan Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Mylan News
...
13 Research Findings and Conclusion
Figure Picture of Narcolepsy Drug
Table Product Specifications of Narcolepsy Drug
Figure Narcolepsy Drug Report Years Considered
Figure Market Research Methodology
Figure Global Narcolepsy Drug Consumption Growth Rate 2013-2023 (Kg)
Figure Global Narcolepsy Drug Value Growth Rate 2013-2023 ($ Millions)
Table Narcolepsy Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Antioxidants Type
Table Major Players of Antioxidants Type
Figure Product Picture of Stimulants Type
Table Major Players of Stimulants Type
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Narcolepsy Drug Consumption Market Share by Type (2013-2018)
Figure Global Narcolepsy Drug Consumption Market Share by Type (2013-2018)
Table Global Narcolepsy Drug Revenue by Type (2013-2018) ($ million)
Table Global Narcolepsy Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Narcolepsy Drug Value Market Share by Type (2013-2018)
Table Global Narcolepsy Drug Sale Price by Type (2013-2018)
Figure Narcolepsy Drug Consumed in Daytime Extreme Sleepiness
Figure Global Narcolepsy Drug Market: Daytime Extreme Sleepiness (2013-2018) (Kg)
Figure Global Narcolepsy Drug Market: Daytime Extreme Sleepiness (2013-2018) ($ Millions)
Figure Global Daytime Extreme Sleepiness YoY Growth ($ Millions)
Figure Narcolepsy Drug Consumed in Cataplexia
Figure Global Narcolepsy Drug Market: Cataplexia (2013-2018) (Kg)
Figure Global Narcolepsy Drug Market: Cataplexia (2013-2018) ($ Millions)
Figure Global Cataplexia YoY Growth ($ Millions)
Figure Narcolepsy Drug Consumed in Others
Figure Global Narcolepsy Drug Market: Others (2013-2018) (Kg)
Figure Global Narcolepsy Drug Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Narcolepsy Drug Consumption Market Share by Application (2013-2018)
Figure Global Narcolepsy Drug Consumption Market Share by Application (2013-2018)
Table Global Narcolepsy Drug Value by Application (2013-2018)
Table Global Narcolepsy Drug Value Market Share by Application (2013-2018)
Figure Global Narcolepsy Drug Value Market Share by Application (2013-2018)
Table Global Narcolepsy Drug Sale Price by Application (2013-2018)
Table Global Narcolepsy Drug Sales by Players (2016-2018) (Kg)
Table Global Narcolepsy Drug Sales Market Share by Players (2016-2018)
Figure Global Narcolepsy Drug Sales Market Share by Players in 2016
Figure Global Narcolepsy Drug Sales Market Share by Players in 2017
Table Global Narcolepsy Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Narcolepsy Drug Revenue Market Share by Players (2016-2018)
Figure Global Narcolepsy Drug Revenue Market Share by Players in 2016
Figure Global Narcolepsy Drug Revenue Market Share by Players in 2017
Table Global Narcolepsy Drug Sale Price by Players (2016-2018)
Figure Global Narcolepsy Drug Sale Price by Players in 2017
Table Global Narcolepsy Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Narcolepsy Drug Products Offered
Table Narcolepsy Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Narcolepsy Drug Consumption by Regions 2013-2018 (Kg)
Table Global Narcolepsy Drug Consumption Market Share by Regions 2013-2018
Figure Global Narcolepsy Drug Consumption Market Share by Regions 2013-2018
Table Global Narcolepsy Drug Value by Regions 2013-2018 ($ Millions)
Table Global Narcolepsy Drug Value Market Share by Regions 2013-2018
Figure Global Narcolepsy Drug Value Market Share by Regions 2013-2018
Figure Americas Narcolepsy Drug Consumption 2013-2018 (Kg)
Figure Americas Narcolepsy Drug Value 2013-2018 ($ Millions)
Figure APAC Narcolepsy Drug Consumption 2013-2018 (Kg)
Figure APAC Narcolepsy Drug Value 2013-2018 ($ Millions)
Figure Europe Narcolepsy Drug Consumption 2013-2018 (Kg)
Figure Europe Narcolepsy Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Narcolepsy Drug Consumption 2013-2018 (Kg)
Figure Middle East & Africa Narcolepsy Drug Value 2013-2018 ($ Millions)
Table Americas Narcolepsy Drug Consumption by Countries (2013-2018) (Kg)
Table Americas Narcolepsy Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Narcolepsy Drug Consumption Market Share by Countries in 2017
Table Americas Narcolepsy Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Narcolepsy Drug Value Market Share by Countries (2013-2018)
Figure Americas Narcolepsy Drug Value Market Share by Countries in 2017
Table Americas Narcolepsy Drug Consumption by Type (2013-2018) (Kg)
Table Americas Narcolepsy Drug Consumption Market Share by Type (2013-2018)
Figure Americas Narcolepsy Drug Consumption Market Share by Type in 2017
Table Americas Narcolepsy Drug Consumption by Application (2013-2018) (Kg)
Table Americas Narcolepsy Drug Consumption Market Share by Application (2013-2018)
Figure Americas Narcolepsy Drug Consumption Market Share by Application in 2017
Figure United States Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure United States Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Canada Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Mexico Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Table APAC Narcolepsy Drug Consumption by Countries (2013-2018) (Kg)
Table APAC Narcolepsy Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Narcolepsy Drug Consumption Market Share by Countries in 2017
Table APAC Narcolepsy Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Narcolepsy Drug Value Market Share by Countries (2013-2018)
Figure APAC Narcolepsy Drug Value Market Share by Countries in 2017
Table APAC Narcolepsy Drug Consumption by Type (2013-2018) (Kg)
Table APAC Narcolepsy Drug Consumption Market Share by Type (2013-2018)
Figure APAC Narcolepsy Drug Consumption Market Share by Type in 2017
Table APAC Narcolepsy Drug Consumption by Application (2013-2018) (Kg)
Table APAC Narcolepsy Drug Consumption Market Share by Application (2013-2018)
Figure APAC Narcolepsy Drug Consumption Market Share by Application in 2017
Figure China Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure China Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Japan Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Korea Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Southeast Asia Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure India Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure India Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Australia Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Table Europe Narcolepsy Drug Consumption by Countries (2013-2018) (Kg)
Table Europe Narcolepsy Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Narcolepsy Drug Consumption Market Share by Countries in 2017
Table Europe Narcolepsy Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Narcolepsy Drug Value Market Share by Countries (2013-2018)
Figure Europe Narcolepsy Drug Value Market Share by Countries in 2017
Table Europe Narcolepsy Drug Consumption by Type (2013-2018) (Kg)
Table Europe Narcolepsy Drug Consumption Market Share by Type (2013-2018)
Figure Europe Narcolepsy Drug Consumption Market Share by Type in 2017
Table Europe Narcolepsy Drug Consumption by Application (2013-2018) (Kg)
Table Europe Narcolepsy Drug Consumption Market Share by Application (2013-2018)
Figure Europe Narcolepsy Drug Consumption Market Share by Application in 2017
Figure Germany Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Germany Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure France Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure France Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure UK Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure UK Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Italy Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Russia Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Spain Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Narcolepsy Drug Consumption by Countries (2013-2018) (Kg)
Table Middle East & Africa Narcolepsy Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Narcolepsy Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Narcolepsy Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Narcolepsy Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Narcolepsy Drug Value Market Share by Countries in 2017
Table Middle East & Africa Narcolepsy Drug Consumption by Type (2013-2018) (Kg)
Table Middle East & Africa Narcolepsy Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Narcolepsy Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Narcolepsy Drug Consumption by Application (2013-2018) (Kg)
Table Middle East & Africa Narcolepsy Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Narcolepsy Drug Consumption Market Share by Application in 2017
Figure Egypt Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Egypt Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure South Africa Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Israel Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure Turkey Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Narcolepsy Drug Consumption Growth 2013-2018 (Kg)
Figure GCC Countries Narcolepsy Drug Value Growth 2013-2018 ($ Millions)
Table Narcolepsy Drug Distributors List
Table Narcolepsy Drug Customer List
Figure Global Narcolepsy Drug Consumption Growth Rate Forecast (2018-2023) (Kg)
Figure Global Narcolepsy Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Narcolepsy Drug Consumption Forecast by Countries (2018-2023) (Kg)
Table Global Narcolepsy Drug Consumption Market Forecast by Regions
Table Global Narcolepsy Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Narcolepsy Drug Value Market Share Forecast by Regions
Figure Americas Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Americas Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure APAC Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure APAC Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Europe Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Europe Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Middle East & Africa Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure United States Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure United States Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Canada Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Canada Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Mexico Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Mexico Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Brazil Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Brazil Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure China Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure China Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Japan Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Japan Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Korea Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Korea Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Southeast Asia Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure India Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure India Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Australia Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Australia Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Germany Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Germany Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure France Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure France Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure UK Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure UK Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Italy Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Italy Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Russia Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Russia Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Spain Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Spain Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Egypt Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Egypt Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure South Africa Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure South Africa Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Israel Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Israel Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure Turkey Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure Turkey Narcolepsy Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Narcolepsy Drug Consumption 2018-2023 (Kg)
Figure GCC Countries Narcolepsy Drug Value 2018-2023 ($ Millions)
Table Global Narcolepsy Drug Consumption Forecast by Type (2018-2023) (Kg)
Table Global Narcolepsy Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Narcolepsy Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Narcolepsy Drug Value Market Share Forecast by Type (2018-2023)
Table Global Narcolepsy Drug Consumption Forecast by Application (2018-2023) (Kg)
Table Global Narcolepsy Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Narcolepsy Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Narcolepsy Drug Value Market Share Forecast by Application (2018-2023)
Table Jazz Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jazz Pharmaceuticals Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Jazz Pharmaceuticals Narcolepsy Drug Market Share (2016-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Pharmaceutical Narcolepsy Drug Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Narcolepsy Drug Market Share (2016-2018)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Narcolepsy Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Narcolepsy Drug Market Share (2016-2018)
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
